Testosterone for women in menopause: evidence, approval and questions to ask

Distressing low desire is a clinical question, not a target number

The best-established evidence concerns carefully assessed hypoactive sexual desire disorder, or HSDD, particularly after menopause. That involves low sexual desire that causes personal distress. A change in frequency or a partner’s expectations does not, by itself, establish a need for hormone treatment.

The assessment should consider pain, other medicines, mood, relationship circumstances and relevant medical conditions. These are parts of understanding the problem, not reasons to dismiss it. The Menopause Society’s sexual-health information describes several possible contributors and treatment approaches rather than one hormone solution for everyone.

A low blood result does not make the diagnosis

The ISSWSH clinical guideline states that a total testosterone value should not be used to diagnose HSDD. Testing has a role in establishing a baseline and monitoring a treatment that is clinically justified. A laboratory result should therefore be interpreted with the history, not treated as an automatic prescription trigger.

If a service recommends testosterone after a panel, ask what diagnosis supports it and what improvement would count as a meaningful benefit. Our menopause blood-test guide explains why measurement and treatment decisions are different steps. Do not use a number from another person’s report as a personal goal.

US approval and off-label use need to be explained

The FDA’s August 2026 notice states that there are no FDA-approved indications for testosterone therapy in menopausal women. Approval in another country does not establish US approval, and the fact that a clinic offers a product does not change its regulatory status.

A clinician may consider off-label prescribing in an appropriate case, with an informed discussion of benefits, risks and alternatives. Ask whether the proposed finished product is approved for a different population or is compounded, since those are separate questions. Our compounding guide explains that distinction.

Be cautious with promises about energy, memory or bones

The British Menopause Society’s May 2026 guidance says randomized trials have not established benefits for cognition, mood, energy or musculoskeletal health. Reports of an individual feeling better do not establish that testosterone is an effective general treatment for those problems.

Ask the prescriber to separate the supported treatment goal from broader wellness marketing. If fatigue or memory problems are the main concern, they deserve an assessment of possible causes. A longevity package, a symptom checklist or a before-and-after story is not a substitute for evidence about the proposed use.

Formulation and monitoring are part of the decision

The ISSWSH guideline discusses carefully monitored transdermal treatment and does not recommend compounded products, pellets or intramuscular injections for women with HSDD. Evidence for one regimen should not be transferred automatically to a different route or a stronger exposure. Do not copy a men’s product dose or adjust an existing prescription yourself.

Ask what monitoring is planned and which changes should be reported. Potential androgen-related effects include acne and excess hair growth; other effects and personal risks require discussion. The FDA notes that long-term safety data beyond two years are limited, including for cardiovascular and breast outcomes. Short-term reassurance is not proof of indefinite safety.

Compare the assessment, not just the availability

The Hone Health review and Hone versus Joi comparison examine providers that advertise testosterone alongside other hormone options. Their inclusion here records the offer; it does not endorse a particular product or imply that treatment is appropriate for you.

Before agreeing to a trial, ask when benefit will be reviewed, what happens if it does not help and who manages adverse effects. If pain or vaginal dryness is affecting intimacy, our vaginal estrogen and moisturizer guide can help prepare that separate conversation. The aim is care matched to your concern, with room to decline a treatment that does not fit.